Page last updated: 2024-08-25

rosiglitazone and triciribine

rosiglitazone has been researched along with triciribine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, J; Liu, L; Liu, Y; Sun, J; Xia, S; Xu, D; Xu, Y; Yang, Z; Zhang, L; Zou, F1

Other Studies

1 other study(ies) available for rosiglitazone and triciribine

ArticleYear
Inhibition of oxidative stress-elicited AKT activation facilitates PPARĪ³ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Glycoproteins; Humans; Liver Neoplasms; Male; Membrane Glycoproteins; Mice; Mice, Nude; NADPH Oxidase 2; NADPH Oxidases; Neoplastic Stem Cells; Oxidative Stress; Peptides; Phenotype; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Ribonucleosides; Rosiglitazone; Thiazolidinediones

2013